Genmab's petosemtamab combination reduced death risk by 50 per cent versus pembrolizumab alone in a Phase 3 head-and-neck ...

Labcorp raises 2026 adjusted EPS guidance to US$18.30 to US$18.70 after quarterly revenue reaches US$3.81 billion and cash ...

Evolution Metals & Technologies reports all 57 equipment containers delivered for a Pohang expansion targeting roughly 10,000 ...

Atico Mining reports copper-gold drilling at El Roble, with true widths estimated at 90 to 95 per cent and a reserve update ...

Brixton Metals proposes up to C$6 million in flow-through shares for exploration, mainly at Thorn in British Columbia and ...

Datavault AI expects a US$92.2 million cut to year-end 2025 assets and is reassessing liquidity after an uncompleted bitcoin withdrawal.

Palvella Therapeutics says FDA accepted its QTORIN rapamycin NDA for priority review, with a Feb. 28, 2027 target and a conditional 2027 launch.

Gold's Oct. 27 morning retreat gave way to a COMEX futures recovery above US$4,070 as miners face cost and earnings tests ...

NiSource narrows its 2026 adjusted earnings outlook and plans US$40 billion in capital spending for 2027 through 2033, ...

CMS Energy reaffirms 2026 adjusted EPS of US$3.83 to US$3.90 as its resource plan outlines investment opportunities and new demand.

SNDL reported C$20 million in quarterly free cash flow, including an insurance benefit, while its IFRS net loss widened to ...

Clavister reports a SEK65 million payment after Norway approved a tactical communications design review, with its next report ...